Efficacy of Nutritional Support and Prehabilitation Before Pancreas Surgery
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-jRCTs031220653
- Lead Sponsor
- Hasegawa Kiyoshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
1. With resectable pancreatic cancer scheduled for neoadjuvant chemotherapy, gemcitabine and S-1, and pancreatic resection
2. ASA performance status of 1-2
3. Aged between 18 and 85 years old at the time of informed consent is taken
4. Male or female
5. Able and willing to give written informed consent with sufficient understanding after having received sufficient explanation
6. Able to attend all scheduled visits
1. Having history of hypersensitivity to component of ENORAS Liquid
2. With milk protein allergy
3. With ileus
4. With loss of bowel function
5. With severe liver diseases, renal diseases or cardiac diseases, judged based on grade 3 of CTCAE v5.0- JCOG
6. Having hemodialysis
7. With disorder of glucose metabolism such as severe diabetes mellitus
8. With congenital disorder of amino acid metabolism
9. Women of childbearing potential, pregnant women or breast-feeding women
10. Disable to having prehabilitation due to impaired cardiopulmonary function
11. Judged as ineligible by clinical investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method